Prohaler® Multi-dose Dry Powder Inhaler

Inhalers, Dry Powder Inhalers

Pharma

Prohaler® is a high performance, multi-dose dry powder inhaler (DPI) that helps to improve patient compliance and adherence in the treatment of respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD). It is activated by simply breathing. It’s lightweight and intuitive design is easy to use and suitable for all patient types.

Download Prohaler Brochure

A Multi-Dose DPI for Improved Patient Compliance

Innovation in Dry Powder Inhalation

Dry powder inhalers are activated by breathing and we developed a high performance, multi-dose dry powder inhaler (DPI) device by focusing on simplicity of use for improved patient compliance.

Innovation in Dry Powder Inhalation

We understand the challenges that asthma and COPD patients face in managing their conditions and maintaining compliance with their treatment regimens. When our dedicated teams of inhalation R&D scientists worked with international thought leaders and patients, their goal was to design and deliver a simple, reliable and intuitive multi-dose dry powder inhaler (DPI) system that would enhance patient compliance and adherence.

We made the device lightweight and portable so that it’s really easy to use. Dose indication and acknowledgement are an integrated part of the design to provide patients with confidence to self-manage their treatment. We designed Prohaler® using the QbD (Quality by Design) approach and this allowed us to ensure that the product meets the desired performance standards, is safe and reliable, and is easy to use by patients. Additionally, the use of QbD enabled us to minimize the risk of product failure and maximize the likelihood of success.

With only three simple steps to operate: Open, Breathe-in, Close (OBIC) practically all patients can use Prohaler®.

Patient focused features

Prohaler® is lightweight and portable and intuitive to use so it can always stay with the patient. It carries up to 30 individual powder doses in separate sealed laminated blisters for optimal moisture protection.

With an integrated visual dose indicator, the user knows if there are doses remaining in the device. Prohaler® also incorporates an audible click noise when the dry powder dose is administered so the user can easily confirm dosing success.

With its unique breath-triggered blister opening mechanism, Prohaler® reduces dose wastage, which can be a common problem with other conventional DPIs.

Integrated Support & Development Services

We are a trusted authority and leading company for the latest innovations in inhalation and dry powder inhaled drug delivery. This is based on our decades long experience in this specialized drug delivery route. Aptar Pharma offers comprehensive development and support services to help our customers derisk and accelerate the process of bringing these important respiratory products to the patients that need them most.

Our extensive knowledge of dry powder inhalation products, our broad range of specialized formulation development, analytical development, technical and regulatory support can help guide customers through the challenging and constantly evolving regulatory approval landscape.  Aptar Pharma is your ideal partner for new or repositioned multi-dose DPI products.

Advantages of Prohaler® Dry Powder Inhaler

  • Easy to use

Prohaler® is simple and intuitive to use, even for emergency use

Simply Open, Breath-in and Close (OBIC) are the three steps required for DPI dosing. Suitable to reliably treat acute or chronic symptoms with no requirement for complicated instructions or complex preparation steps.

Let Us Help you Find the Optimal Respiratory Solution for Patient Compliance.

Contact us now and benefit from our proven know-how in innovative inhalation solutions.

request more information

This Might Also Be of Interest

22 Apr 2024

Navigating the Shift to more sustainable Low GWP propellants in pMDIs

Publications, Pharmaceutical, Product Solutions, Sustainability, Brand Differentiation, Market Insights

Read More
26 Mar 2024

Optimizing Preclinical Studies for Intranasal and Pulmonary Programs

Webinars, Pharmaceutical, Device Innovations, Market Insights, Product Solutions, Innovation & Insights

Read More
13 Mar 2024

In Silico Modelling for Orally Inhaled Drug Development (OINDP)

Webinars, Pharmaceutical, Innovation & Insights, Market Insights, Product Solutions

Read More
7 Mar 2024

Sustainable Propellants and Bioequivalence Innovation in OINDPs

Publications, Pharmaceutical, Market Insights, Product Solutions, Innovation & Insights

Read More
1 2 3 4 19

We Have a Broad Range of Value Added Services to Accelerate and Derisk Your Drug Product Development.

DISCOVER APTAR PHARMA’S SERVICES

Start a Project With Us

We Thrive on Transforming Ideas into Opportunities – Let Yours be Next.

Contact a Pharma Expert

We Offer World-Leading Support Services for You at Every Stage of Your Product Development

Request More Information

Close

Requesting information on Prohaler® Multi-dose Dry Powder Inhaler.

  • 0 of 40 max characters
  • 0 of 40 max characters
  • 0 of 40 max characters
  • 0 of 950 max characters
  • * Required. For details, read our General Terms and Conditions of Use, Privacy and Cookies Policy.
  • This field is for validation purposes and should be left unchanged.
Back To Top